medications

Provided

Researchers at the University of Cincinnati are conducting a clinical trial to determine if a new drug, cabotegravir (CAB), is a safe and effective method of protection from HIV. The UC clinical trial is part of a study being done by the HIV Prevention Trials Network.

Ann Thompson’s Focus on Technology reports researchers are developing tissue chips that accurately model human organs, such as the lungs, liver and heart. As a result, scientists at Cincinnati Children’s and others may be able to test new drugs faster, safer, and more cost effectively than present methods.